This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Inverness Medical Innovations Q1 2010 Earnings Call Transcript

Inverness Medical Innovations (IMA)

Q1 2010 Earnings Call

April 28, 2010 10:00 am ET


Doug Guarino - Director of Corporate Communications & Corporate Relations

David Teitel - Chief Financial Officer, Principal Accounting Officer, Vice President and Treasurer

Ron Zwanziger - Chairman of the Board, Chief Executive Officer and President


Bruce Cranna - Jefferies & Company, Inc.

Ashim Anand - Natixis Bleichroeder Inc.

Erik Schneider - UBS Investment Bank

Bill Bonello - RBC Capital Markets Corporation

Jonathan Groberg - Macquarie Research

Jeff Ares

Gregory Simpson - Stifel, Nicolaus & Co., Inc.

Mark Afrasiabi - PIMCO

John Putnam - Capstone Investments

Zarak Khurshid - Caris & Company

Constantine Davides - JMP Securities LLC

Daniel Owczarski - Avondale Partners LLC



Good morning, and welcome to the First Quarter Earnings Conference Call. My name is Suzette, and I will be facilitating the audio portion of today's interactive broadcast. [Operator Instructions] At this time, I would like to turn the event over to Doug Guarino, Director of Corporate Relations. Sir, you may begin your conference.

Doug Guarino

Well, thank you, Suzette, and good morning, and welcome to the Inverness Medical Innovations Conference Call to discuss our results for the quarter and year ended March 31, 2010. We are joined today by Ron Zwanziger, Chairman and CEO; and Dave Teitel, our CFO.

Before we get to that discussion though, I would first like to draw your attention to the fact that certain matters discussed in this conference call will constitute forward-looking statements within the meaning of U.S. securities laws. These statements reflect our current views with respect to future events of financial performance and are based on management’s current assumptions and information currently available.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs